Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others. The antipsychotic drugs market is expected to grow due to the rising number of Schizophrenic patients. However, patent expiration of major brands could negatively impact the market growth. Deep-dive analysis of global antipsychotic drugs market focuses on major market dynamics such as drivers, restrains and opportunities. Competitive landscape section profiles the key players on the basis of business performance, strategic moves and SWOT analysis. Profound analysis of segments would be helpful to understand the product distribution trends in each segment within the global antipsychotic drugs market.

High prevalence of Schizophrenia and psychotic disorders are the prime drivers for global antipsychotic drugs market. Increased drug abuse, over prescription of drugs and addiction to antipsychotic drugs are the additional factors that drive the market growth for antipsychotic drugs. However, patent expiry of major brands over the past few years had negative impact on market growth and  it has been responsible to the rising competition from generic drug manufacturer. Serious side effects such as tardive dyskinesia, associated with antipsychotics also restraints the market growth. Emerging economies are the opportunistic markets for antipsychotics due to large pool of aging population, which has high risk of psychosis, and increased healthcare awareness. 

Global Antipsychotic Drugs Market by Brands

The global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and Third generation antipsychotic drugs. Except Halodol and lithium carbonate, all first generation antipsychotic agents are called as standard or typical antipsychotics, as they act similar i.e., interference with neurotransmitters. Second generation antipsychotics are also known as atypical antipsychotic agents and act as broad-spectrum antagonists of dopamine, serotonin and alpha-noradrenergic receptors. With development of technology and growing competition to gain largest market share, researchers are focusing on first generation antipsychotics to better understand their working mechanism. Abilify and Seroquel are topmost marketed brands due their high therapeutic efficacy and reduced side effects. 

Global Antipsychotic Drugs Market by Application

The global antipsychotic drugs are used to treat different brain disorders such as Schizophrenia, Bipolar disorder, Dementia, Unipolar Depression and Others. The drugs used in Schizophrenia and psychotic depression are expected to boost the growth of antipsychotic drugs market due to increasing incidences of these two conditions.

Global Antipsychotic Drugs Market by Geography

Geographically, global antipsychotic drugs market is segmented into North America, Europe, Asia-Pacific and LAMEA. Antipsychotics are the largely prescribed drugs in the North American region due to large patient pool suffering from mental and psychotic disorders. Asia-Pacific and LAMEA are the lucrative market for global antipsychotic drugs manufacturers, due to large patient pool and rising healthcare awareness. 

Competitive Landscape

The key players within global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this maket. Generic competition is soaring due to patent expiration of six largest antipsychotic drugs in 2012. 

 High Level Analysis  

The comprehensive analysis of global antipsychotic drugs market provides an overview of the market and its key concerns. Market segmentation is concentric towards product distribution trends of each segment that would be helpful to strategist in deciding on the market segments. Market dynamics covers market drivers, restrains and opportunities, which would help to understand the market behaviour. Porter’s Five Forces analysis would be helpful in determining the market profitability. Buyers bargaining power is high for global antipsychotic drugs market due to patent expiration of major brands and availability of many generic medicines in the marketplace. Global antipsychotic drugs market has high threat from new entrants as major brands have lost their patent protection in 2012. Industrial rivalry is intense due to entry of numerous generic competitors, which forces big players to manipulate their drug prices according to changing market trends. 

KEY BENEFITS

• This report offers the following benefits in particular:

• Complete analysis of drivers, restrains and opportunities within global antipsychotic drugs market would assist professionals to understand the market behavior 

• Profound assessment of geography focuses on niche market areas and provides forward looking perspective

• Porter’s Five Forces framework would assist strategist in decision making by analyzing the market profitability within global antipsychotic drugs market

• Comprehensive assessment of key leaders and their market strategies for global antipsychotic drugs market would be informative to professionals in the corporate sector 

KEY DELIVERABLES

The global antipsychotic drugs market is segmented into two major categories such as technology and geography. 

MARKET BY BRANDS

• First Generation Drugs (Standard / Typical Antipsychotic Agents) 

  • Thorazine (Chlorpromazine HCl) 

  • Serentil (Mesoridazine Besylate) 

  • Mellaril (Thioridazine HCl) 

  • Haldol (Haloperidol) 

  • Loxitane (Loxapine Succinate) 

  • Trilafon (Perphenazine)

  • Navane (Thiothixene) 

  • Sordinol (Clopenthixol)

  • Others

• Second generation Drugs  (Atypical Antipsychotic Agents)

  • Zyprexa (Olanzapine) 

  • Geodon (Ziprasidone) 

  • Seroquel (Quetiapine) 

  • Risperdal (Risperidone)

  • Clozaril (Clozapine)

  • Invega (Paliperidone) 

  • Asendin (Amoxapine)

  • Latuda (Lurasidone)

  • Others

• Third generation Drugs 

  • Abilify (Aripiprazole)

MARKET BY APPLICATION

• Schizophrenia

• Bipolar Disorder

• Dementia

• Unipolar Depression

• Other

MARKET BY GEOGRAPHY

• North America